Pharmacogenomics in Autism Treatment

NCT00584701 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Autism

Interventions

DRUG: Risperidone

Sponsor

University of California, San Francisco

Collaborators

[object Object]
[object Object]